Pi-xiao Wang

发表

An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury

Hongliang Li, Xinliang Ma, Zan Huang, 2017, Nature Medicine.

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis

Feng Li, Hongliang Li, P. Zhang, 2018, Nature Medicine.

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis

Hongliang Li, Zan Huang, Xiao-Jing Zhang, 2016, Hepatology.

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Hong Jin, Zhi‐Ren Zhang, Hongliang Li, 2016, Journal of hepatology.

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Hongliang Li, Aibing Wang, Mei Xiang, 2016, Journal of hepatology.

Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.

Hongliang Li, Sijun Yang, J. Qin, 2016, The American journal of pathology.

Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury.

De-Pei Liu, Hongliang Li, Ling Huang, 2015, Journal of hepatology.

Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor &bgr;–Activated Kinase 1–Dependent Signaling Pathways

Hongliang Li, G. Ma, Lijuan Chen, 2017, Hypertension.

Tripartite motif 32 prevents pathological cardiac hypertrophy

Hongliang Li, G. Ma, Lijuan Chen, 2016, Clinical science.

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis

Feng Li, Hongliang Li, Xinliang Ma, 2017, Nature Medicine.

Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Hypertension.

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

Hongliang Li, Zan Huang, Xiao-Jing Zhang, 2016, Nature Communications.

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling

Hongliang Li, Sijun Yang, Xiao-Jing Zhang, 2016, Nature Communications.

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Lu Gao, Hongliang Li, Xiao-Jing Zhang, 2016, Journal of hepatology.

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

Hongliang Li, Aibing Wang, Xiao-Jing Zhang, 2016, Journal of hepatology.

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Nature Medicine.

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Nature Medicine.

Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice

Feng Li, Zan Huang, Aibing Wang, 2019, Hepatology.

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

P. Zhang, Zan Huang, Zhi‐Gang She, 2017, Nature Medicine.

Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver

Zhi‐Gang She, Yi-da Tang, Yan‐Xiao Ji, 2018, Hepatology.

Reprogramming Innate Immune Signaling in Cardiometabolic Disease

Hongliang Li, Xiao-Jing Zhang, Peng Zhang, 2017, Hypertension.

Interferon regulatory factor 9 is critical for neointima formation following vascular injury

De-Pei Liu, Lu Gao, Hongliang Li, 2014, Nature Communications.

Regulator of G‐protein signalling 5 protects against atherosclerosis in apolipoprotein E‐deficient mice

Hongliang Li, Cheng Du, Yan Zhang, 2015, British journal of pharmacology.

Interferon regulatory factor 3 protects against adverse neo-intima formation.

Ke Chen, Hongliang Li, D. Jiang, 2014, Cardiovascular research.

Mindin deficiency protects the liver against ischemia/reperfusion injury.

Hongliang Li, Peng Zhang, S. Tian, 2015, Journal of hepatology.

Interferon Regulatory Factor 8 Modulates Phenotypic Switching of Smooth Muscle Cells by Regulating the Activity of Myocardin

Lu Gao, Hongliang Li, Ling Huang, 2013, Molecular and Cellular Biology.

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance

Yaling Han, Chenghui Yan, Yanxia Liu, 2017, Hepatology.

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Lu Gao, Hongliang Li, Xiao-Jing Zhang, 2016, Journal of hepatology.

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

Hongliang Li, Aibing Wang, Xiao-Jing Zhang, 2016, Journal of hepatology.

Interferon Regulatory Factor 8 Modulates Phenotypic Switching of Smooth Muscle Cells

Lu Gao, Hongliang Li, Ling Huang, 2013 .

Liver capsule: IRFs in hepatocytes: Pathophysiology

Hongliang Li, Xiao-Jing Zhang, Pi-xiao Wang, 2016, Hepatology.

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Hong Jin, Zhi‐Ren Zhang, Hongliang Li, 2016, Journal of hepatology.

Regulator of G‐protein signalling 5 protects against atherosclerosis in apolipoprotein E‐deficient mice

Hongliang Li, Cheng Du, Yan Zhang, 2015, British journal of pharmacology.